Industry News
Pharmaceutical Industry News
Fierce Pharma Asia—FDA oncology czar on China PD-1 rebuff; US Senate’s supply chain bill; Insilico’s AI targets
Fierce Pharma Asia—FDA oncology czar on China PD-1 rebuff; US Senate's supply chain bill; Insilico's AI targets aliu Fri, 04/01/2022 - 07:37
Gilead zeros in with community groups around the world to help end AIDS epidemic
Gilead zeros in with community groups around the world to help end AIDS epidemic sharon.coey Fri, 04/01/2022 - 06:36
Novo Nordisk, trying to switch patients to Rybelsus, launches new TV ad
Novo Nordisk, trying to switch patients to Rybelsus, launches new TV ad badams Fri, 04/01/2022 - 03:52
House Passes Bill to Limit Cost of Insulin to $35 a Month
The bill stands to benefit millions of Americans with diabetes, but to become law, it will need to attract at least 10 Republican votes in the Senate
Gilead’s Kite flies higher as Yescarta leads CAR-T therapy class to earlier lymphoma treatment
Gilead’s Kite flies higher as Yescarta leads CAR-T therapy class to earlier lymphoma treatment aliu Thu, 03/31/2022 - 12:16
Cómo preparase para la subvariante de ómicron BA.2
Tomar estas siete medidas ahora puede reducir tu riesgo y minimizar la perturbación en la vida de tu familia.
Boehringer goes bold with ‘unwearable’ fashion to spotlight patients’ rare skin disease pain
Boehringer goes bold with 'unwearable' fashion to spotlight patients' rare skin disease pain nmissakian Thu, 03/31/2022 - 10:22
Preparing manufacturers for a changing copay landscape
Preparing manufacturers for a changing copay landscape mwen Thu, 03/31/2022 - 09:52
Feds probe ring of counterfeit HIV meds targeting Gilead, GlaxoSmithKline and Johnson & Johnson: report
Feds probe ring of counterfeit HIV meds targeting Gilead, GlaxoSmithKline and Johnson & Johnson: report kdunleavy Thu, 03/31/2022 - 09:49
Targeting GSK and AstraZeneca, Clovis lifts sinking Rubraca with broad ovarian cancer win
Targeting GSK and AstraZeneca, Clovis lifts sinking Rubraca with broad ovarian cancer win aliu Thu, 03/31/2022 - 09:24
Bayer sheds some sites in €2B push to expand next-gen manufacturing capabilities
Bayer sheds some sites in €2B push to expand next-gen manufacturing capabilities jkeenan Thu, 03/31/2022 - 08:16
Novavax, hoping to bump up its lagging European launch, asks EMA to authorize its COVID shot in teenagers
Novavax, hoping to bump up its lagging European launch, asks EMA to authorize its COVID shot in teenagers badams Thu, 03/31/2022 - 07:13
Zealand becomes a lesson in the rigors of commercialization as a slow launch triggers 90% staff cut, CEO exit
Zealand becomes a lesson in the rigors of commercialization as a slow launch triggers 90% staff cut, CEO exit badams Thu, 03/31/2022 - 04:39
‘Extreme disappointment’: With FDA snub of Akebia’s vadadustat, another oral anemia med bites the dust
'Extreme disappointment': With FDA snub of Akebia's vadadustat, another oral anemia med bites the dust kdunleavy Wed, 03/30/2022 - 21:47
New ALS Treatment, AMX0035, Lacks Evidence of Benefit, FDA Panel Finds
With a 6-4 vote, the group of independent advisers to the agency narrowly concluded that results from another clinical trial are needed to assess whether the therapy, called AMX0035, can help patients.
Ivermectin Does Not Reduce Risk of Covid Hospitalization, Large Study Finds
“At some point it will become a waste of resources to continue studying an unpromising approach,” one expert said.
Senate blesses bill to wrest US supply chains from China’s grasp, with pharma front and center
Senate blesses bill to wrest US supply chains from China's grasp, with pharma front and center fkansteiner Wed, 03/30/2022 - 15:54
How to Prepare for BA.2, the Omicron Subvariant
Taking these seven steps now can lower your risk and minimize the disruption to your family’s life.
Teva, AbbVie ink opioid settlements worth nearly $330M with Florida
Teva, AbbVie ink opioid settlements worth nearly $330M with Florida esagonowsky Wed, 03/30/2022 - 14:47
In a year of big growth for AbbVie, CEO Richard Gonzalez scored $24M pay package
In a year of big growth for AbbVie, CEO Richard Gonzalez scored $24M pay package kdunleavy Wed, 03/30/2022 - 13:27